Skip to content

Efficacy of acupuncture in the treatment of moderate-to-severe atopic dermatitis: a multicentre randomised sham-controlled clinical trial

Efficacy of acupuncture in the treatment of moderate-to-severe atopic dermatitis: a multicentre randomised sham-controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000683
Enrollment
Unknown
Registered
2025-04-10
Start date
2025-04-13
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atopic dermatitis

Interventions

Alternate control group:No treatment
acupuncture group:acupuncture

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Meet the diagnostic criteria for moderate to severe atopic dermatitis; 2) Age =18 and =75 years old gender is not limited; 3) Peak Pruritus Numerical Rating Scale (PP-NRS) score =4; 4) Voluntarily participate in this trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Patients who are in the acute onset of the disease and have erosions exudates and secondary infections; 2) Patients who have participated in other clinical studies in the past 3 months or are participating in other clinical studies; 3) Patients with severe haematological diseases (e.g. platelet count <50×109 /L) and other serious diseases that may affect operation and efficacy; 4) Current systematic use of glucocorticosteroids discontinued for less than 7 days; immunosuppressants (cyclosporine methotrexate tretinoin etc.) discontinued for less than 1 month; dulprevirizumab discontinued for less than 1 month JAK inhibitors discontinued for less than 2 weeks; 5) Women who are pregnant or breastfeeding; 6) Patients with a history of acupuncture treatment.

Design outcomes

Primary

MeasureTime frame
SCORAD;

Secondary

MeasureTime frame
neuECG;Serum total IgE;POEM;DLQI;Peripheral blood serum cytokines;PP-NRS;

Countries

China

Contacts

Public Contactfu-lun li

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Shanghai University of Traditional Chinese Medicine

drlifulun@163.com18918757260

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026